2370 Medinet
- 40
- -1-2.44%
Medinet News
Medinet: Notice Concerning Election of Director Candidates and Audit & Supervisory Board Candidates
Medinet: Notice Concerning Decrease in Capital and Capital Reserve Amounts and Disposal of Surplus Funds
Medinet: Notice regarding the recording of non-operating income and extraordinary losses
Medinet: Summary of Financial Results 2024
Medinet: Explanatory materials on business plans and growth potential
Medinet: [Progress of disclosure matters] Decision to discontinue development of regenerative medicine products for the purpose of treating chronic heart failure
Medinet: Notice regarding mass exercise and completion of exercise of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment
Medinet: Strategic partnership agreement signed with AGC for cell therapy CDMO business
Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment
Medinet: Announcements of individual stocks regarding the recognition of non-operating revenue.
Medinet: Overview of Q3 2024 financial results.
Medinet: Started manufacturing outsourcing for a new specified cell processed product ("S-DSC") related to hair regeneration.
Medinet: (Progress of disclosure matters) **** regulatory authorities have approved the provision of γδT cell therapy at new medical institutions (progress of licensing agreement with Medigen Biotechnology Corp.)
Medinet: Notice Concerning the Recording of Non-Operating Income and Non-Operating Expenses
Medinet: Summary of financial results for the 2nd quarter of 2024
Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment
Medinet: (Progress of disclosure matters) Taiwan regulatory authorities approve provision of gamma-delta T cell therapy at new medical institutions
Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment
Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment
Medinet: (Progress of disclosure matters) Taiwan regulatory authorities approve provision of gamma-delta T cell therapy at new medical institutions
Analysis
Price Target
No Data
No Data